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Glycoprotein folding is mediated by lectin-like chaperones and protein disulfide isomerases (PDIs) in the endoplasmic
reticulum. Calnexin and the PDI homologue ERp57 work together to help fold nascent polypeptides with glycans located
toward the N-terminus of a protein, whereas PDI and BiP may engage proteins that lack glycans or have sugars toward
the C-terminus. In this study, we show that the PDI homologue PDILT is expressed exclusively in postmeiotic male germ
cells, in contrast to the ubiquitous expression of many other PDI family members in the testis. PDILT is induced during
puberty and represents the first example of a PDI family member under developmental control. We find that PDILT is not
active as an oxido-reductase, but interacts with the model peptide -somatostatin and nonnative bovine pancreatic trypsin
inhibitor in vitro, indicative of chaperone activity. In vivo, PDILT forms a tissue-specific chaperone complex with the
calnexin homologue calmegin. The identification of a redox-inactive chaperone partnership defines a new system of
testis-specific protein folding with implications for male fertility.
INTRODUCTION
Protein disulfide isomerase (PDI) catalyzes the formation,
isomerization and reduction of disulfide bonds in the endo-
plasmic reticulum (ER). More than 17 mammalian PDI ho-
mologues have been identified all characterized by the pres-
ence of one or more thioredoxin folds (Ellgaard and
Ruddock, 2005). PDI itself contains four of these thioredoxin
domains: two with the thioredoxin redox active site CXXC
(designated a-type domains) and two domains lacking the
active site (designated b-type domains). The b-type domains
lack redox activity, but have either a structural function or
are involved in substrate recognition and binding (Klappa et
al., 1998a). In PDI, these domains have an a-b-b-a organi-
zation. PDIp, ERp57, and PDILT share the same domain
structure with PDI, but various other configurations of thi-
oredoxin domains exist in other PDI family members, with
most PDIs containing at least one a-type domain with an
intact active site motif (Ellgaard and Ruddock, 2005).
PDI homologues are not functionally equivalent, as
shown by differences in their ability to complement a yeast
strain deficient for PDI (Gunther et al., 1993; Kramer et al.,
2001). Furthermore, the different PDI family members inter-
act with discrete sets of substrates. PDI catalyzes in vitro
redox reactions in a wide variety of substrates, including
bovine pancreatic trypsin inhibitor (BPTI), insulin, and ribo-
nuclease (Weissman and Kim, 1993; Zheng and Gilbert,
2001). PDI also displays chaperone activity toward nondis-
ulfide bond–containing substrates (Cai et al., 1994) and
forms the noncatalytic subunit in prolyl 4-hydroxylase
(Koivu et al., 1987) and microsomal triglyceride transfer
complex (Wetterau et al., 1990). ERp57 interacts with a spe-
cific set of glycosylated proteins that are recruited via its
interaction with the lectins calnexin/calreticulin (Oliver et
al., 1997; Jessop et al., 2007) and is a component of the major
histocompatibility complex (MHC) class I loading complex
(Lindquist et al., 1998; Dick et al., 2002). ERp72 has been
found in association with a number of immature or unfolded
proteins, including MHC class II and thyroglobulin (Schaiff
et al., 1992; Kuznetsov et al., 1994) and has been implicated in
ER retention of misfolded proteins (Forster et al., 2006). The
pancreas-specific PDIp binds unfolded proteins and specif-
ically recognizes tryptophan and tyrosine residues in sub-
strates (Klappa et al., 1998b; Ruddock et al., 2000). Therefore,
multiple PDI homologues may be required for substrate-
specific folding.
Two PDI-like proteins, ERp44 and PDILT, have ER lume-
nal a-type domains, but lack the canonical active site motif,
whereas ERp27 and ERp28 are devoid of a-type domains
(Ferrari et al., 1998; Anelli et al., 2002; van Lith et al., 2005;
Alanen et al., 2006). Most PDI family members are ubiqui-
tously expressed, although a few PDI family members such
as endoPDI, PDIp, and PDILT have a restricted tissue dis-
tribution. PDIp expression is mostly limited to the pancreas
(Desilva et al., 1996; Dias-Gunasekara et al., 2005). Although
PDIp may have overlapping substrate specificities with
PDI, it could serve as a specific folding catalyst for a
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subset of pancreatic secretory proteins (Ruddock et al.,
2000). EndoPDI/ERp46, with three CxxC thioredoxin mo-
tifs, is highly expressed in endothelial cells where it has a
protective role during hypoxia (Sullivan et al., 2003). The
third PDI family member with restricted tissue expression is
PDILT.
We have recently identified PDILT as a PDI homologue
that is specifically expressed in testis (van Lith et al., 2005).
The testis has two distinct compartments: the seminiferous
tubules, which contain differentiating germ cells supported
by somatic Sertoli cells, and an interstitium containing Ley-
dig cells, peritubular cells, and blood vessels. Germ cell
maturation (spermatogenesis) is a complex process; during
the first phase, diploid spermatogonia undergo rounds of
mitotic replication before entering a second, lengthy, meiotic
prophase that culminates in two rounds of cell division to
yield haploid spermatids. During the third phase, known as
spermiogenesis, the spermatids undergo extensive remodel-
ing characterized by loss of somatic histones, DNA compac-
tion, cessation of DNA transcription, and development of a
flagellum (Hess, 1990). Within the seminiferous epithelium
the germ cells at different phases of maturation are arranged
in constant associations known as “stages” with the diploid
spermatogonia at the periphery of the tubules and the most
mature, haploid, elongate spermatids proximal to the lumen
(Hess, 1990; Russell et al., 1990).
In the present study, we set out to determine PDILT
expression and function in the testis. Although calnexin
interacts with ERp57 to support disulfide bond formation in
newly synthesized glycoproteins in somatic cells (Oliver et
al., 1997), we identify PDILT as a partner for the testis-
specific calnexin homologue calmegin in postmeiotic male
germ cells. Our data suggest that PDILT-calmegin com-
plexes are required as a specialized chaperone system for
spermatogenesis-specific proteins during the final stages of
germ cell maturation.
MATERIALS AND METHODS
Cell Lines, Tissues, and Antibodies
Human cervical carcinoma HeLa cells were maintained in minimal Eagle’s
medium (Invitrogen, Carlsbad, CA) supplemented with 8% fetal calf serum
(Sigma, St. Louis, MO), 2 mM glutamax, 100 U/ml penicillin, and 100 g/ml
streptomycin (Invitrogen).
Tissues for immunoprecipitation/Western blot analysis and immunohisto-
chemistry were obtained from rats (SD) and mice (C57/B6 or CD1). Sections
of testes from human, stump-tailed macaque, and common marmoset were
from blocks of fixed tissue held in an archive at the Human Reproductive
Sciences Unit Edinburgh.
The anti-HA (HA-7; Sigma), anti-myc (9B11; Cell Signaling, Beverly, MA),
anti-ERp72 (Calbiochem, La Jolla, CA) and anti-BiP (H-129; Santa Cruz Biotech-
nology, Santa Cruz, CA) antibodies were commercially available. The PDILT
antiserum was raised against purified recombinant His-tagged PDILT; this anti-
serum was used in all experiments, except where noted. The anti-peptide PDILT
antiserum was raised against the PDILT peptide RQKLINDSTNKQELN coupled
to hemocyanin and was a kind gift from Dr. L. Ellgaard (University of Copen-
hagen, Denmark). The polyclonal antiserum against PDI has been described
(Benham et al., 2000), and the mAb against PDI was obtained from Affinity
BioReagents (Golden, CO). The anti-ERp57 antiserum was a kind gift from Prof.
N. Bulleid (University of Manchester, England). The calmegin antiserum was a
kind gift from Prof. Y. Nishimune (The Research Institute of Microbial Diseases,
Osaka, Japan). The calnexin antiserum was a kind gift from Prof. I. Braakman
(University of Utrecht, The Netherlands).
Constructs
Construction of human PDILT with a C-terminal myc-tag has been de-
scribed previously (van Lith et al., 2005). The PDILT cysteine-to-alanine
mutants were generated from this construct using Quik Change Site-
Directed Mutagenesis kit (Stratagene, La Jolla, CA) using primers GTCA-
GAGCCCATCAGCGCCAAAGGAGTGGTTGAATC/GATTCAACCACTC-
CTTTGGCGCTGATGGGCTCTGAC (PDILT C135A) and GCACCCTG-
GTCTAAAAAGGCCAAGATGCTGTTCCCAC/GTGGGAACAGCATCTT-
GGCCTTTTTAGACCAGGGTGC (PDILT C420A). For biophysical analysis,
mature PDILT (S21-L584) was cloned into pLWRP51, a modified pET23b vector
(Novagen, Madison, WI), which encodes an N-terminal His tag (MHHHHHHM)
before the first amino acid of the protein sequence, using the primers TTTTTTT-
TCATATGTCACCAGAGGTTAACGCCGGTG and TTTTTTTTGGATCCTTAT
TAAAGTTCTTCCTTGACTTTTGGTTTCTTCTTTTGC. The PDILT-HA construct
was a kind gift from Dr. L. Ellgaard. All plasmids generated were verified by
sequencing.
Transfections
Transfections with Lipofectamine 2000 (Invitrogen) were done according to
the manufacturer’s instructions. Subconfluent cells in 6-cm dishes were
washed with Hanks’ balanced salt solution and Optimem and transfected
with 1 g of DNA for 6 h in the presence of Optimem serum-free medium.
After 6 h the cells were washed and returned to normal growth medium. The
cells were analyzed 24 h after transfection.
RNA Isolation and RT-PCR
Total RNA from rat tissues was extracted using TRI reagent (Sigma) accord-
ing to the manufacturer’s instructions. The RNA concentration was deter-
mined by spectrophotometry to ensure equal total RNA input. RT-PCR was
performed with the AccessQuick kit (Promega, Madison, WI) using 50 ng
RNA on a Peltier Thermal Cycler (MJ Research, Waltham, MA). Sense and
antisense primers were designed on different exons to exclude amplification
of contaminating genomic DNA: PDILT (set 1), CATCGTTGGCTTCTTCCAG
and TATTTTGGAATCTCTTCACTGG; PDILT (set 2), CCATGTGCTCAAG-
CAGGAAC and CACTCAGAAACTGATGTCAGGAC; calmegin, CACCT-
CAACCTATAGGAGAAG and CTTCATCTCATCCTCTGATCC; PDI, AAG-
GAATATACAGCTGGCAG and CCTTCTTCAGGCCAAAGAAC; and actin,
CCACACCTTCTACAATGAGC and ACTCCTGCTTGCTGATCCAC.
PCR products were analyzed on 1% agarose gels.
Immunoprecipitations and Western Blotting
Cells and tissues were lysed in 1% Triton X-100, 50 mM Tris (pH 8.0), 150 mM
NaCl, and 5 mM EDTA, supplemented with 20 mM iodo-acetic acid (IAA)
and protease inhibitors. Postnuclear lysates were incubated with protein A
Sepharose beads (Sigma) and antisera for 1–2 h at 4°C. After extensive
washing of the beads, immunoprecipitated proteins were eluted by boiling in
sample buffer and analyzed by 8% SDS-PAGE. Proteins were transferred to
polyvinylidene difluoride membranes (Millipore, Bedford, MA) at 150 mA for
2 h. The membranes were blocked in Tris-buffered saline Tween (TBST) with
8% milk, followed by incubation with primary antibody at the following
concentrations: 1:2000 anti-myc and anti-HA, 1:10,000 anti-PDILT, and 1:1000
anti-PDI and anti-calmegin. After washing three times with TBST, the mem-
branes were incubated with secondary antibodies (DAKO, High Wycombe,
Bucks., United Kingdom), washed, and visualized by electrochemilumines-
cence (ECL; Amersham/GE Healthcare, Little Chalfont, United Kingdom)
and exposure to film (Eastman Kodak, Rochester, NY). Protein markers were
from Bio-Rad.
Endoglycosidase H Treatment
Samples were treated with endoglycosidase H (endoH) according to the
manufacturer’s protocol (New England Biolabs, Beverly, MA). Briefly, lysates
cleared by centrifugation were 2-mercaptoethanol–reduced and SDS-dena-
tured followed by incubation without or with endoH in 50 mM sodium citrate
(pH 5.5) at 37°C for 16 h and analyzed by SDS-PAGE.
Immunohistochemistry
Testicular tissues were fixed in Bouins solution, processed into paraffin wax
according to standard procedures and cut in 4-m-thick sections onto poly-
lysine slides (VWR Scientific Products, West Chester, PA). Wax was removed
with Histoclear (Agar Scientific, Stansted, United Kingdom), and the tissue
was rehydrated in sequential washing steps from 100 to 70% ethanol. Endog-
enous peroxidase activity was blocked with 1% hydrogen peroxide in meth-
anol. Antigen retrieval was done by incubating the slides in 10 mM sodium
citrate at 90°C for 30 min. After a blocking step in phosphate-buffered saline
(PBS) with 5% goat serum and 0.2% bovine serum albumin (BSA), the sections
were incubated with primary antibodies in PBS with 0.2% BSA. Primary
antibodies were detected with the ABC kit (DAKO) followed by developing
with 3,3-diaminobenzidine (DAB; Sigma). Sections were counterstained with
hematoxylin. Slides were mounted with 1,3-diethyl-8-phenylxanthine (DPX;
Agar Scientific) and analyzed with an inverted microscope (Axiovert 10,
Zeiss, Thornwood, NY).
Purification of Human Recombinant PDILT
His-tagged PDILT was expressed in the Escherichia coli strain BL21 (DE3)
pLysS in LB medium at 37°C by inducing with 1 mM isopropyl -d-thiogal-
actoside at an OD600 of 0.3 for 4 h. After pelleting at 8000 rpm for 10 min, the
pellet was resuspended in one-tenth volume of 20 mM sodium phosphate (pH
7.3) with 10 g/ml DNase (Roche, Indianapolis, IN). The cells were lysed by
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freeze-thawing twice, and the insoluble material was collected by centrifuga-
tion (9000 rpm for 20 min). The pellet was washed twice with 20 ml of 50 mM
Tris, 10 mM EDTA, 0.5% Triton X-100 (pH 8.0), twice with distilled water, and
centrifuged at 9000 rpm for 20 min between each wash. PDILT was recovered
from the washed pellet by solubilizing in 20 ml of 5 M guanidine hydrochlo-
ride/50 mM Tris (pH 8.75), with the insoluble material removed by centrif-
ugation at 9000 rpm for 20 min. The soluble fraction was incubated in 10 mM
dithiothreitol (DTT) at room temperature for 30 min. Excess DTT was re-
moved by gel filtration using a PD-10 column (GE Healthcare) which had
been pre-equilibrated in 5 M guanidine hydrochloride, 0.2 M sodium phos-
phate (pH 7.0). Solubilized His-PDILT was loaded onto a His-Trap column
(GE Healthcare) and refolded on-column by a linear buffer exchange from 3
M guanidine/0.2 M sodium phosphate (pH 7.0) to 0.2 M sodium phosphate
(pH 7.0) over 4 h. PDILT was eluted from the column with 50 mM EDTA, 20
mM sodium phosphate (pH 7.0).
Purified Rat PDI was a gift from N. Bulleid.
Biophysical Analysis
Far UV circular dichroism spectra were obtained on a Jasco J810 Spectropo-
larimeter (Easton, MD). Data were collected using 0.1 mg/ml PDILT at 25°C
as an average of eight scans, using a cell with a path length of 0.1 cm,
measured at a scan speed of 20 nm/min, a spectral bandwidth of 1.0 nm, and
a time constant of 0.5 s. The maximum HT voltage was below 600 V.
Fluorescence spectra were collected on a PerkinElmer Life Sciences LS50
spectrophotometer (Boston, MA) using a 1-ml cuvette. Data were collected at
25°C as an average of four scans, excitation at 280 nm, emission at 300–400
nm, slit widths of 5 nm, and a scan speed of 200 nm/min. Protein stocks were
diluted 20-fold to a final concentration of 2 M into 0.2 M phosphate buffer,
pH 7.0, containing 0–6 M guanidine hydrochloride and equilibrated for 5 min
at 25°C before fluorescence spectra were recorded. All spectra were corrected
for the blank spectra with no protein added. The fluorescence parameter
examined to observe the effects of guanidine hydrochloride on protein struc-
ture was the ratio of the average fluorescence intensity 2 nm either side of the
max for native protein to the average fluorescence intensity over the range
320–400 nm. This parameter was chosen because it is independent of con-
centration and less dependent on the direct effects of guanidine hydrochloride
on tryptophan fluorescence.
Oxido-reductase Assays
For the insulin-reduction assay, human insulin (Sigma) at a final concentra-
tion of 0.17 mM was incubated with 1 M PDILT or PDI in the presence of 5
mM DTT. Precipitation of the insulin B chain was monitored by measuring
OD600 at 5-min intervals after addition of insulin.
To monitor protein oxidation and isomerization, 70 M of recombinant
bovine pancreatic trypsin inhibitor (BPTI) in 0.1 M Tris buffer, pH 7.5, or 0.1
M phosphate buffer, pH 6.0, both containing 1 mM EDTA, 2 mM reduced
glutathione (GSH), and 0.5 mM oxidized glutathione was incubated with and
without 10 M of PDILT. Disulfide bond formation of BPTI was monitored by
trapping thiol-disulfide exchange by treating with 1.1 M iodoacetamide,
desalting the sample, and analyzing it by electrospray mass spectrometry
(Micromass, Manchester, United Kingdom).
The protein oxidation assay using a fluorescent decapeptide with 3.2 M
peptide substrate and 0.2 M PDILT has been described (Ruddock et al.,
1996). Deglutathionylation activity was monitored as described previously
(Peltoniemi et al., 2006), using 0.2 M PDILT in the presence of 1 mM GSH
and 5 M substrate peptide. Glutathionylation activity was determined as
described previously (Peltoniemi et al., 2006), using 0.2 M PDILT and 5.4 M
substrate peptide.
Peptide-binding Assay
Cell extracts from E. coli BL21 (DE3) pLysS were prepared by repeated freeze-
thawing. Bolton-Hunter 125I-labeling of -somatostatin (AGSKNFFWKTFSS)
was performed as recommended by the manufacturer (Amersham Pharmacia
Biotech, Piscataway, NJ). Cross-linking was performed using the homobifunc-
tional cross-linking reagent disuccinimidyl glutarate (Sigma) as described
(Klappa et al., 1998a). As a positive control an E. coli lysate expressing ERp27
(Alanen et al., 2006) was used. This lysate was prepared as detailed for the
purification of PDILT, except that because ERp27 is solubly expressed, the
soluble postlysis material was used.
RESULTS
Biophysical Characterization of PDILT
PDILT shares almost 50% sequence similarity with PDI, with
the most notable differences being the altered active site
motifs in PDILT (SXXS and SXXC) and a free cysteine at
position 135 in the first catalytic domain. C135 is conserved
in PDILT between species, but is not found in other PDI
family members. As PDI has both redox and chaperone-like
properties, we wanted to see whether these functions were
retained in PDILT. Therefore, we purified and refolded a
His-tagged version of PDILT from a bacterial lysate to near-
purity as shown on a Coomassie-stained SDS-PAGE gel
(Figure 1A). Mass spectrometry analysis of the purified pro-
tein gave the correct mass (65612.5 Da) for a single sodium
adduct of the protein. The far-UV circular dichroism spec-
trum suggested that PDILT was structured and contained a
significant amount of -helix and -sheet (Figure 1B). Ma-
ture PDILT contains three tryptophans, and the fluorescence
spectra of PDILT under nondenaturing conditions gave a
max of 334 nm (Figure 1C), indicative of a tryptophan
residue being in a hydrophobic environment. On addition of
6 M guanidinium chloride the fluorescence spectra of PDILT
had a max of 354 nm, indicative of a denatured protein.
Fluorescence-based denaturation curves for PDILT showed
a multiple-phase transition from the native to the denatured
state (Figure 1D), similar to that observed for PDI (Morjana
et al., 1993). The midpoint of the fluorescence change be-
tween 0 and 6 M guanidinium chloride was around 3.5 M,
higher than that of any domain of PDI, indicating that the
purified PDILT was structured.
Human PDILT contains two cysteine residues: one in the
catalytic site of the second catalytic domain (C420) and one
away from the catalytic site in the first catalytic domain, but
at a position suitable for PDI-substrate interactions (C135).
Under nondenaturing conditions PDILT has a free sulfhy-
dryl content of 2.1, as determined by the Ellman’s reagent
assay (data not shown), implying that both cysteines are
solvent accessible. In addition, when lysates from HeLa cells
transfected with PDILT were analyzed by nonreducing SDS-
PAGE, PDILT was engaged in disulfide-linked complexes
(Figure 1E, lane 1). Replacement of either cysteine with
alanine resulted in the loss of some, but not all complexes,
showing that each cysteine mediates distinct disulfide-
linked complexes (Figure 1E, lanes 2 and 3). As expected,
mutation of both cysteines abolished all disulfide-linked
PDILT complexes (Figure 1E, lane 4). Thus, the PDILT cys-
teines are solvent exposed, both in vitro and in vivo.
Because both cysteines of PDILT are solvent exposed, we
next examined if PDILT had oxido-reductase activity. PDI
catalyzes a wide range of thiol-disulfide exchange reactions,
including reduction of disulfides, oxidation of dithiols to a
disulfide, and reductive removal of a glutathione moiety
from a protein-glutathione mixed disulfide (Ruddock et al.,
1996; Peltoniemi et al., 2006). First, we used an insulin re-
duction assay (Holmgren, 1979) to establish whether PDILT
had reductase activity. When PDI was incubated with insu-
lin in the presence of DTT, the insulin B chain rapidly
precipitated as expected (Figure 1F, PDI). In contrast, PDILT
did not display any reductase activity over the nonenzy-
matic reduction of insulin alone (Figure 1F, compare PDILT
vs. insulin), suggesting that PDILT is not a conventional
disulfide oxidoreductase. Similarly, PDILT does not show
any peptide oxidation activity toward a decapeptide sub-
strate (Ruddock et al., 1996), nor does it show any degluta-
thionylation activity toward a glutathionylated octapeptide
(Peltoniemi et al., 2006) nor glutathionylation activity toward
a nonglutathionylated version of the same octapeptide (data
not shown).
In contrast to these results, PDILT-substrate interactions
were observed in a BPTI refolding assay. BPTI has been
widely used to study PDI-catalyzed protein refolding
(Weissman and Kim, 1993). Reduced BPTI is soluble, as is
purified PDILT, but when they were combined, a precipitate
formed rapidly. Analysis of the precipitate by SDS-PAGE
showed that it contained both proteins, indicating a PDILT-
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BPTI interaction (data not shown). Because PDI is able to
interact with peptides and proteins that do not contain cys-
teines, we next examined whether PDILT engages in similar
interactions by using a -somatostatin cross-linking assay.
The 14-amino acid peptide -somatostatin has previously
been used to examine peptide/nonnative protein-binding
sites in other PDI family members, including PDI (Klappa et
al., 1998a), PDIp (Klappa et al., 1998b), and ERp27 (Alanen et
al., 2006). When radiolabeled -somatostatin is added to
suitable lysates, specific cross-linking with these PDI family
members can be observed by autoradiography of SDS-PAGE
gels. When PDILT was used in the -somatostatin assay, a
weak band was observed at the expected position of PDILT
in an E. coli lysate that had 2 g of purified PDILT added to
it (Figure 1G, lane 1). These bacteria expressed human
ERp27 as an internal control. Because the PDILT band was
not visible in the control samples (Figure 1G, lane 2), this
shows that PDILT interacts with -somatostatin indepen-
dently of substrate cysteines.
Expression of PDILT Is Restricted to a Subset of Germ
Cells
To gain further insight into the function of PDILT in vivo,
we raised a polyclonal antiserum against recombinant puri-
fied human PDILT. The antiserum specifically recognized
both transfected PDILT in HeLa cells (Figure 2A) and en-
dogenous PDILT in mouse testis (Figure 2B). The antiserum
did not detect PDILT in nontesticular tissues (Figure 2B, top
panel), whereas PDI and calnexin were detected in all tissues
examined (Figure 2B, bottom panel), corroborating the tes-
tis-specific expression of PDILT reported previously (van
Lith et al., 2005).
Having demonstrated the specificity of the PDILT anti-
serum, we used immunohistochemistry on rat testis sections
counterstained with hematoxylin to determine the cellular
Figure 1. PDILT has chaperone-like proper-
ties. (A) Purified human His-tagged PDILT
and purified rat PDI were analyzed by SDS-
PAGE and Coomassie staining. (B) Far-UV
circular dichroism spectrum of purified re-
combinant human PDILT. (C) Fluorescence
spectra of purified human His-tagged PDILT
under native (Gnd) and denaturing condi-
tions (Gnd). (D) Guanidine hydrochloride
denaturing curve of purified human His-
tagged PDILT. Shown is the ratio of the aver-
age fluorescence intensity at 332–336 nm
(peak of native protein) to that at 320–400 nm.
(E) HeLa cells were mock-transfected or trans-
fected with myc-tagged wild-type PDILT or
the PDILT cysteine mutants as indicated. Ly-
sates of these transfectants were analyzed by
nonreducing (lanes 1–5) and reducing (lanes
6–10) SDS-PAGE. Monomeric PDILT (PDILT-
SH) and PDILT in disulfide-linked complexes
(PDILT-SS-*) are indicated. Molecular weights
in kDa are indicated on the right-hand side.
(F) Human insulin, 0.17 mM, was incubated
with DTT only (insulin) or DTT with 1 M
enzyme (PDI or PDILT) in PBS. Insulin with-
out DTT (insulin-DTT) was indistinguishable
from PBS. The OD600 was monitored over 30
min to follow precipitation of the insulin B
chain. (G) Extracts of E. coli expressing ERp27
were incubated with 125I-labeled -somatosta-
tin with (lane 1) or without (lane 2) 2 g
recombinant PDILT. After cross-linking with
disuccinimidyl glutarate, the samples were
analyzed by SDS-PAGE.
Figure 2. Specificity of the PDILT antiserum. (A) Lysates from
HeLa cells transfected with PDILT-myc or an irrelevant myc con-
struct were analyzed by Western blotting with a rabbit antiserum
raised against purified recombinant His-tagged human PDILT. (B)
Equal amounts (in mg of tissue) of murine tissue lysates were
analyzed by Western blotting with a rabbit antiserum raised against
purified recombinant His-tagged human PDILT (top), anti-PDI
(middle), and anti-calnexin (bottom).
M. van Lith et al.
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site of PDILT expression. The preimmune serum showed
minor staining in the interstitial areas of rat testis due to
residual trapped serum (Figure 3A, rat-NRS) and was indis-
tinguishable from secondary antibody alone (data not
shown). In contrast, the anti-PDILT serum intensely stained
populations of germ cells in the seminiferous tubules (Figure
3A, rat-PDILT). The immunostaining pattern was essen-
tially the same for mouse testis (Figure 3A, mouse-PDILT)
and when using the antiserum raised against a PDILT pep-
tide [Figure 3A, mouse-PDILT (pep)]. PDILT expression
was also restricted to germ cells in testis from human, ma-
caque, and marmoset (Figure 3B). Although in rat, mouse,
and macaque, cross-sections of individual tubules are char-
acterized as containing a single grouping (spermatogenic
stage) of germ cells (Hess, 1990), the organization of sper-
matogenesis in human and the common marmoset is more
complex, and tubule cross-sections contain germ cell com-
plements typical of a mixture of stages (Schulze et al., 1986;
Millar et al., 2000). The restricted expression pattern of
PDILT to a subset of germ cells was in stark contrast with the
expression patterns of other PDI family members PDI,
ERp57, and ERp72 or the ER chaperone BiP. Although ex-
pression levels varied between the different cell types within
the seminiferous tubules, expression of these other PDI fam-
ily members was ubiquitous throughout the seminiferous
epithelium (Figure 3C). Thus, PDILT is expressed in testis of
multiple mammalian species and in contrast to other PDI
family members, its expression is restricted to a subset of
testicular germ cells.
PDILT Is Expressed in Postmeiotic Germ Cells
Closer examination of adult rat testis sections showed that
PDILT was present in the most mature germ cells, located
around the seminiferous tubule lumen (Figure 4A). When
evaluated using the standard spermatogenic staging scheme
(Figure 4B), it was apparent that immunopositive staining
was first detectable in haploid round spermatids found at
stage VII. In all species examined, the onset of PDILT ex-
pression commenced upon completion of meiotic prophase.
Thereafter, in the rat PDILT was present in the cell body of
all subsequent round and elongating spermatids (Figure 4A,
stages IX, XI, and XIV). PDILT was not detected in sperma-
tozoa in the epididymis or in the ejaculate (data not shown;
Ellerman et al., 2006), consistent with the finding that PDILT
was not found in the nuclei of the spermatozoa but could be
detected in apical and basal residual bodies (Figure 4A,
stage XI) that are left behind when spermatozoa are released
(Clermont et al., 1987). The germ cells to which PDILT was
localized are summarized on a diagram that shows the germ
cells associations found in the different stages of spermato-
genesis in the rat (Figure 4B).
PDILT Expression Is under Developmental Control
As PDILT was first seen at the round spermatid stage, we
asked whether the onset of PDILT expression coincides with
the appearance of differentiating germ cells during the first
wave of spermatogenesis in development. Total RNA, iso-
lated from rat testes at different ages, was used for RT-PCR
to determine the expression of PDILT with age. A cDNA
containing the coding region of PDILT gave a product of
expected size (Figure 5A, PDILT 1). No product was ob-
served when using RNA derived from testes of 2- and
15-d-old rats, demonstrating that PDILT was not expressed
in somatic cells that make up the bulk of the testes at these
ages. PDILT mRNA was detected in testis from day 30 and
reached adult levels from day 45 onward. RNA from liver of
a 58-d-old rat served as negative control (Figure 5A, PDILT
Figure 3. Expression of PDILT is germ cell specific. (A) Sections
from rat testis counterstained with hematoxylin (blue) were immu-
nostained with normal rabbit serum (NRS) or an anti-PDILT serum
raised against recombinant PDILT at a dilution of 1:8000 (top pan-
els). The PDILT staining pattern (brown) is similar for mouse testis
(bottom left) or when using a serum raised against an internal
PDILT peptide at 1:1000 (bottom right). Scale bar, 200 m. (B) Testis
sections from human, macaque, and marmoset were immuno-
stained for PDILT. Although a single population of PDILT-positive
germ cells occupied the full circumference of the tubule in macaque,
the staining on human and marmoset was more heterogenous con-
sistent with the existence of tubules containing more than one stage
of spermatogenesis in a single cross section. Scale bar, 100 m. (C)
Rat testis sections were immunostained for ERp57, ERp72, PDI, and
BiP (brown). Expression of these proteins was observed throughout
the seminiferous epithelium. Scale bar, 200 m.
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1). Similar results were obtained when using a second
primer set that spanned the entire PDILT coding sequence
(Figure 5A, PDILT 2), confirming that expression of PDILT
mRNA starts between days 16 and 30. Note the absence of
product from the cDNA with this second primer set, as these
primers were designed outside the coding region contained
in the cDNA. There were no additional products in any of
the RT-PCRs on rat testes or liver with these primers, show-
ing that there are no alternative PDILT splicing products.
The developmentally regulated expression of PDILT con-
trasts with the expression of PDI, as PDI mRNA was present
in testis and liver of rats throughout postnatal development
(Figure 5A).
We also compared the expression of PDILT with that of
calmegin, a testis-specific homologue of the chaperone
calnexin. Calmegin is expressed in differentiating male
germ cells upon the appearance of pachytene spermato-
cytes (Watanabe et al., 1994). RT-PCR showed that calme-
gin is readily detected in testis from day 30 onward,
consistent with the presence of pachytene spermatocytes
at this age (Figure 5A).
To determine the relationship between mRNA levels and
protein expression, testes and liver from rats were lysed and
analyzed by Western blotting. PDILT was completely absent
in testes from 2- and 15-d-old rats. Consistent with the
RT-PCR results, PDILT could be detected at day 30 (on very
Figure 4. Germ cell expression of PDILT from stage VII. (A) Rat
testis sections immunostained with anti-PDILT from Figure 3A
were imaged at higher magnification. Four representative sections
from stages VII, IX, XI, and XIV of the rat spermatogenic cycle are
shown. A higher detailed section, indicated by a box, is shown
below each stage. Round spermatids (R), elongate spermatids (E),
and immunonegative pachytene spermatocytes (P) and germ cells
undergoing meiotic division (m2) are indicated. At stage VII mature
elongate spermatids ready for release are indicated by arrows. At
stage IX immunopositive staining was particularly intense in small
areas (arrowheads) that are likely to be the residual cytoplasmic
remnants from spermatozoa released at stage VII. (B) A staging
diagram showing the germ cell associations characteristic of the
spermatogenic cycle (Russell et al., 1990) summarizes the expression
levels of PDILT (gray shading) in the adult rat.
Figure 5. Expression of PDILT commences during the first wave of
spermatogenesis. (A) Total RNA extracted from testis of 2-, 15-, 30-,
45-, and 58-d-old rats was used for RT-PCR using primer sets
specific for PDILT, calmegin, PDI, and actin. As a positive control,
cDNA was used for PDILT, calmegin, and PDI. PDILT primer set 1
was designed on 2 internal exons, whereas PDILT primer set 2 was
designed on the first and last exons, to exclude expression of alter-
natively spliced variants during development. (B) Testis and liver
from 2-, 15-, 30-, 45-, and 58-d-old rats were lysed and analyzed by
Western blotting for PDILT, calmegin, and PDI. (C) Testis sections
from 21-, 28-, 31-, 38-, 45-d-old and adult rats were counterstained
with hematoxylin (blue) and immunostained for PDILT (brown).
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long exposures, data not shown) and reached adult levels of
expression by day 45. (Figure 5B). Calmegin reached adult
levels of expression by day 30, whereas PDI was expressed
throughout postnatal development (Figure 5B). To examine
whether the onset of PDILT expression corresponds with the
first appearance of round spermatids in development, sec-
tions of testes from rats of different ages were taken for
immunohistochemistry. PDILT was not detected in any so-
matic cells or germ cells in testis from 21- and 28-d-old rats.
On day 31, some of the seminiferous tubules contained
PDILT-positive cells close to the tubule lumen. The propor-
tion of seminiferous tubules containing PDILT-positive cells
dramatically increased with age and by day 45, all of the
seminiferous tubules were positive for PDILT (Figure 5C).
Taken together, these data show that PDILT expression is
detected in testis from 30-d-old rats, consistent with the
appearance of round spermatids during the first spermato-
genic wave at puberty. This strongly suggests that PDILT is
under developmental control and has a role in sperm differ-
entiation.
PDILT Is a Calmegin-interacting Protein
To understand PDILT behavior and function in the ER, we
investigated whether any PDILT-protein interactions could
be detected, either in transfected cells or in testis tissue. As
some thioredoxin family members (Zhao et al., 2003) and
redox enzymes (Dias-Gunasekara et al., 2005) form ho-
modimers, we first explored whether PDILT is able to self-
associate. Given that spermatids are difficult to isolate and
transfect, PDILT-myc and an HA-tagged version were ex-
pressed in HeLa cells, either alone or together. Cell lysates
were subjected to immunoprecipitation with anti-myc or
anti-HA antibodies and analyzed by reducing SDS-PAGE
and Western blotting. Both PDILT-myc and PDILT-HA were
expressed as expected (Figure 6, lanes 1–3) and anti-myc and
anti-HA antibodies pulled down PDILT-myc and PDILT-
HA, respectively (Figure 6, lanes 5 and 7, top panel, and
lanes 10 and 11, bottom panel) showing that immunopre-
cipitations were successful. Anti-myc and anti-HA also co-
immunoprecipitated PDILT-HA and PDILT-myc, respec-
tively, from double transfectants (Figure 6, lane 7, bottom
panel, and lane 11, top panel), indicating that PDILT-myc
and PDILT-HA interacted. Anti-myc and anti-HA did not
directly immunoprecipitate PDILT-HA and PDILT-myc
(Figure 6, lane 6, bottom panel, and lane 9, top panel),
demonstrating the specificity of the immunoprecipitations.
In addition, the interaction did not occur postlysis because
no interaction could be detected when lysates of single
transfectants were mixed (data not shown). To determine
whether PDILT homodimers are disulfide-linked, we coex-
pressed PDILT-HA with PDILT-myc C135A/C420A that
lacks cysteines and is therefore unable to form mixed
disulfides. Anti-myc and anti-HA coimmunoprecipitated
PDILT-HA and PDILT-myc C135/C420 (Figure 6, lane 8,
bottom panel, and lane 12, top panel), showing that the
interaction was not disulfide-linked. Thus, in addition to
forming disulfide-linked complexes (Figure 1E), PDILT
can engage with itself in a noncovalent complex.
We next analyzed endogenous PDILT-protein interactions
in testis tissue. The onset of expression and the staining
pattern of PDILT resembles that of calmegin (Figure 5).
Because both proteins are testis-specific homologues of ubiq-
uitously expressed counterparts involved in protein folding,
we explored the possibility that PDILT and calmegin inter-
acted. Testis and liver lysates were either directly analyzed
or subjected to immunoprecipitation with anti-PDILT or
anti-calmegin, followed by Western blotting for PDILT and
calmegin. Both PDILT and calmegin are present in testis, but
not in liver (Figure 7A, lanes 1 and 2). The antisera against
PDILT and calmegin immunoprecipitated PDILT (Figure
7A, lane 4, top panel) and calmegin (Figure 7A, lane 6,
bottom panel), respectively. Significantly, PDILT interacted
with calmegin (Figure 7A, lane 6, top panel) and vice versa,
calmegin coimmunoprecipitated, albeit more weakly, with
PDILT (Figure 7A, lane 4, bottom panel). Anti-calmegin did
not directly immunoprecipitate PDILT from a HeLa PDILT-
myc lysate, showing the specificity of the immunoprecipita-
tion (Figure 7B). The interaction between the testis proteins
PDILT and calmegin is specific as neither PDI (Figure 7C,
lane 6, WB CMG and lane 4, WB: PDI) nor ERp57 (Figure
7C, lane 4, WB: ERp57) could be detected in calmegin
immunoprecipitates from testis lysates.
The PDILT-Calmegin Interaction Is Glycan-independent
Both calnexin and calmegin interact with nascent glycopro-
teins in a glycan-dependent way (Ikawa et al., 1997). Because
PDILT itself is glycosylated, PDILT could be one of these
glycoproteins requiring assistance from calmegin to fold.
Alternatively, PDILT could be a novel, nonredox active part-
ner for calmegin. To distinguish between these possibilities,
mouse liver and testis lysates were mock-treated or treated
with endoH to remove glycans. EndoH treatment resulted in
an increased electrophoretic mobility of PDILT, consistent
with the removal of the PDILT glycans (Figure 7D, lanes 3
and 4, top panel) and confirming that endogenous PDILT is
an ER-resident protein (van Lith et al., 2005). Calmegin is not
glycosylated, and its mobility remained unchanged upon
endoH treatment (Figure 7D, lanes 3 and 4, bottom panel).
Deglycosylation had no effect on the efficiency of immuno-
precipitation of PDILT or calmegin (Figure 7D, lanes 7 and 8,
top panel, and lanes 11 and 12, bottom panel). The anti-
calmegin and anti-PDILT antisera coimmunoprecipitated
PDILT and, more weakly, calmegin, respectively, from both
mock- and endoH-treated samples (Figure 7D, lanes 11 and
12, and 7 and 8), indicating that the calmegin/PDILT inter-
action was glycan-independent. These results suggest that
PDILT is not merely a substrate for calmegin, but rather a
partner for this lectin-like protein. The postmeiotic cells of
the testes therefore host a unique ER chaperone complex,
Figure 6. PDILT self-associates. Wild-type (wt) or cysteine mutant
(C135A/C420A, denoted CA) HA- or myc-tagged PDILT was ex-
pressed in HeLa cells as indicated. Lysates were directly analyzed
(lanes 1–4) or subjected to immunoprecipitation with anti-myc
(lanes 5–8) or anti-HA (lanes 9–12) before SDS-PAGE and Western
blotting with anti-HA (bottom panel) and anti-myc (top panel). The
asterisk indicates the bands for the antibodies used for the immu-
noprecipitations.
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distinct from the redox-active ERp57-calnexin and BiP-PDI
partnerships observed for glycoprotein folding in somatic
cells (Molinari and Helenius, 2000).
DISCUSSION
The coordination of protein folding in the ER of different
tissues in vivo is not well characterized. It has recently
become apparent that the physiology of tissue-specific
folding, misfolding, and quality control will be central to
diseases including those of the pancreas (e.g., diabetes;
Ozcan et al., 2006) and the CNS (e.g., Alzheimer’s Disease;
Uehara et al., 2006). The testes present a special case for
the control of ER protein folding because of the unusual
environment; besides experiencing low temperature, de-
veloping germ cells also require a new proteome and
extensive organelle remodeling to produce the acrosome
for sperm– egg fusion.
We have used a range of methods to determine the
expression of an unusual, testis-specific, PDI homologue,
PDILT. PDILT is exclusively found in postmeiotic germ
cells (Figure 3A), an expression pattern that is conserved
in mouse, rat, marmoset, macaque, and human (Figure 3,
A and B). This is in dramatic contrast to other members of
the PDI protein family, including ERp57, ERp72, and PDI,
which are expressed in all cell types of the testis (Figure
3C). PDILT was not detected in testes at 21 or 28 d of
life, at a time when the most mature germ cell type was
the pachytene spermatocyte (Clermont and Perey, 1957),
but PDILT was detectable in testicular extracts and in cells
near the lumen of seminiferous tubules by day 30 or 31, a
time when the most mature germ cell types are haploid
round spermatids (Figure 4). Thus PDILT seems to be
required during spermiogenesis when round spermatids
differentiate into mature spermatozoa. These dramatic
morphological changes are accompanied by the appear-
ance of many transcripts unique to this cell type, a num-
ber of which are also translationally regulated (Hecht,
1990). Proteins unique to the haploid germ cells include
testis-specific histones, transition proteins and prota-
mines, all of which are essential for the correct packaging
of DNA into the sperm head (Yu et al., 2000; Adham et al.,
2001) and proteins essential for the formation of the ac-
rosome (Hurst et al., 1998) and flagellum (Brohmann et al.,
1997). Male haploid germ cells also often express genes
that are variants of somatically expressed genes (Lin and
Morrison-Bogorad, 1991; Hecht, 1998), and PDILT and
calmegin may represent such examples.
PDILT shows the same domain architecture as PDI,
ERp57, and PDIp (Ellgaard and Ruddock, 2005), but has a
number of significant differences. Most notably, PDILT lacks
three of the four active site cysteine residues and other
residues required for redox activity, such as the equivalent
to R120 in PDI (Lappi et al., 2004). It is therefore not surpris-
ing that PDILT is not catalytically active as a thiol-disulfide
oxidoreductase in any of the standard in vitro assays. How-
ever, human PDILT does have two surface-exposed cysteine
residues, and these mediate distinct mixed disulfide com-
plexes in cells (Figure 1E). In addition, PDILT does form
complexes with the peptide -somatostatin (Figure 1G) and
the nonnative protein BPTI (data not shown). Because both
nonnative BPTI and PDILT are soluble in isolation but
quickly form aggregates when combined, the interaction
between these proteins must result in a significant confor-
mational change in at least one of them, probably caused by
PDILT binding to hydrophobic residues in BPTI with sub-
sequent exposure of other hydrophobic residues. PDI has
three distinct substrate-binding sites (Koivunen et al., 2005)
and does not form aggregates in vitro, whereas ERp57 has
one of these sites specialized for the interaction with calre-
ticulin/calnexin (Russell et al., 2004) and does form aggre-
gates in vitro with nonnative BPTI and other nonnative
proteins (Karala and Ruddock, unpublished observation).
PDILT forms a complex with calmegin (Figure 7), consistent
with in vitro aggregation occurring to the PDI-family mem-
bers that are part of a lectin complex in vivo.
Although an indirect interaction between PDILT and
calmegin cannot be formally excluded, the association be-
Figure 7. PDILT interacts with calmegin. (A) Lysates from mouse
liver and testis were either directly analyzed (lanes l and 2) or
subjected to immunoprecipitation with anti-PDILT (lanes 3 and 4)
or anti-calmegin (lanes 5 and 6) before analysis by SDS-PAGE and
Western blotting with anti-PDILT (top panel) and anti-calmegin
(bottom panel). (B) Lysates from HeLa cells transfected with PDILT-
myc were directly analyzed (lane 1) or subjected to immunoprecipi-
tation with anti-myc (lane 2) and anti-calmegin (lane 3). All samples
were analyzed by SDS-PAGE and Western blotting with anti-myc.
(C) Lysates from rat liver and testis were either directly analyzed
(lanes 1 and 2) or subjected to immunoprecipitation with anti-
calmegin (lanes 3 and 4) or anti-PDI (lanes 5 and 6) before analysis
by SDS-PAGE and Western blotting with anti-calmegin, anti-PDI
(mouse monoclonal), and anti-ERp57. The asterisk indicates cross-
reactive antibodies used for the immunoprecipitation in lanes 3 and
4. (D) Lysates from mouse liver and testis were treated with endoH
and either directly analyzed (lanes 1–4) or subjected to immuno-
precipitation with anti-PDILT (lanes 5–8) or anti-calmegin (lanes
9–12) before analysis by SDS-PAGE and Western blotting with
anti-PDILT (top panel) and anti-calmegin (bottom panel). The ar-
rowhead indicates glycosylated PDILT, and the arrow indicates
deglycosylated PDILT. The asterisk indicates a background band
occasionally observed.
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tween the two proteins in the ER of spermatids is glycan-
independent (Figure 7). Thus, PDILT is not just a glycosy-
lated substrate for calmegin, but is more likely to be a
partner in a unique protein-folding system. Our inability to
detect calmegin-ERp57 and calmegin-PDI complexes in tes-
tis suggests that the PDILT-calmegin complex performs a
unique role in ER quality control, although some caution is
required in interpreting negative immunoprecipitation data
(Figure 7C). Because PDILT has no oxido-reductase activity
in vitro and lacks the classical WCGHC motif of standard
oxidoreductases, it is likely that PDILT operates as a folding
assistant for spermatid-specific glycoproteins that have been
ensnared by calmegin. This is supported by the observation
that calmegin interacts with nascent glycoproteins (Ikawa et
al., 1997) and our finding that PDILT interacts in vitro with
the model peptide -somatostatin and the nonnative protein
BPTI (Figure 1). The fact that PDILT can be recovered in
disulfide dependent complexes from transfected cells (Fig-
ure 1E) and as complexes from testes (van Lith et al., 2005)
suggests that both PDILTs solvent-exposed cysteine resi-
dues may trap free single cysteines in substrates, perhaps
using them as a molecular handle to facilitate protein fold-
ing of the peptide backbone. Whether noncovalent PDILT-
PDILT complexes (Figure 6) have an independent functional
role in vivo, or perhaps operate as an inactive chaperone
reservoir, requires further investigation. Together, our work
identifies a new quality control hub unique to the ER of
spermatids, alongside the ERp57/calnexin and BiP/PDI
partnerships found in somatic cells (Molinari and Helenius,
2000). Although calnexin presents nonnative glycoproteins
to the redox-active ERp57, the glycan recognition is de-
coupled from the redox activity for the PDILT/calmegin
pair. It will now be important to determine whether calme-
gin and PDILT work on similar or independent substrates to
ERp57 and PDI, given that both PDI and ERp57 are also
expressed in postmeiotic cells (Figure 3C). Now that ap-
proaches to determine the substrate specificity of ERp57
have been successful (Jessop et al., 2007), it should be possi-
ble to identify the range of endogenous PDILT substrates by
proteomics and the in vivo role of PDILT homodimerization
(Figure 6), once the limitations of transfecting and culturing
germ cells have been overcome.
Another interesting possibility is that PDILT is required
for specific events during meiosis, such as remodeling the
ER in preparation for acrosome formation and the expulsion
of the cytoplasmic body. Both PDI and ERp29 are involved
in ERAD of microbial proteins (Tsai and Rapoport, 2002;
Magnuson et al., 2005), and it may be that PDILT is required
for unfolding and retrotranslocation of ER proteins during
the programmed disposal of the residual body. Further-
more, ERp57 is found at the surface of sperm and is required
for disulfide bond exchange in preparation for gamete fu-
sion (Ellerman et al., 2006). The C-terminal QEDL motif of
ERp57 is inefficiently retrieved by the KDEL receptors,
meaning that ERp57 may be more reliant on its associa-
tion with ER-resident proteins for its retention than other
PDIs (Raykhel, Alananen, and Ruddock, unpublished
data). Thus one possibility is that PDILT regulates ERp57
export to the cell surface by competing with ERp57 for
calmegin and calnexin and allowing monomeric ERp57 to
be exported from the ER. In vitro experiments with the
purified, glycosylated components will be required to deter-
mine the relative affinities of these proteins for each other.
Calmegin is required for fertility (Ikawa et al., 1997),
and it will be important to determine whether PDILT-
deficient mice are also infertile. With many human male
infertility cases unexplained, identifying genes and path-
ways associated with infertility remains a public health
priority.
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